Ticker
NVO

Price
195.40
Stock movement up
+0.02 (0.01%)
Company name
Novo Nordisk A/S
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
439.62B
Ent value
584.73B
Price/Sales
2.48
Price/Book
5.27
Div yield
0.90%
Div growth
10.20%
Growth years
-
FCF payout
102.95%
Trailing P/E
7.92
Forward P/E
37.36
PEG
5.74
EPS growth
5.90%
1 year return
86.40%
3 year return
44.26%
5 year return
31.98%
10 year return
19.33%
Last updated: 2023-09-08
Get the latest news and real-time alerts from Novo Nordisk A/S (NVO) stock at Seeking Alpha.
September 20, 2023

iO Charts is a Seeking Alpha partner

Novo Nordisk announced a share split, aiming to enhance share price appreciation and facilitate options trading for investors. Learn more on NONOF stock here.
September 20, 2023

iO Charts is a Seeking Alpha partner

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share1.77
Dividend yield0.90%
Payout frequencySemi-annual
Maximum yield3.74%
Average yield1.87%
Minimum yield0.62%
Discount to avg yield-106.24%
Upside potential-51.51%
Yield as % of max yield24.18%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield0.90%
Current yield distribution86.67%
Yield at 100% (Min)0.62%
Yield at 90%0.83%
Yield at 80%1.11%
Yield at 50% (Median)1.57%
Yield at 20%2.75%
Yield at 10%3.13%
Yield at 0% (Max)3.74%

Dividend per share

Loading...
Dividend per share data
Years of growth-
CCC status-
Dividend per share1.77
Payout frequencySemi-annual
Ex-div date18 Aug 2023
EPS (TTM)24.48
EPS (1y forward)5.23
EPS growth (5y)5.90%
EPS growth (5y forward)1.38%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
NVOS&P500
DGR MR51.41%8.78%
DGR TTM13.59%8.57%
DGR 3 years2.61%4.00%
DGR 5 years10.20%5.65%
DGR 10 years13.72%7.37%
DGR 15 years17.11%5.83%
Time since last change announced44 days
EPS growth (5y)5.90%
EPS growth (5y forward)1.38%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM119.40%102.95%
Average--
Forward33.79%-
Loading...
AD

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E7.92
Price to OCF5.57
Price to FCF6.83
Price to EBITDA5.74
EV to EBITDA7.63

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales2.48
Price to Book5.27
EV to Sales3.30
Get the latest news and real-time alerts from Novo Nordisk A/S (NVO) stock at Seeking Alpha.
September 20, 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Novo Nordisk A/S (NVO) stock at Seeking Alpha.
September 13, 2023

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count2.25B
EPS (TTM)24.48
FCF per share (TTM)28.39

Income statement

Loading...
Income statement data
Revenue (TTM)176.95B
Gross profit (TTM)148.51B
Operating income (TTM)74.81B
Net income (TTM)55.52B
EPS (TTM)24.48
EPS (1y forward)5.23

Margins

Loading...
Margins data
Gross margin (TTM)83.92%
Operating margin (TTM)42.28%
Profit margin (TTM)31.38%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash12.65B
Net receivables57.51B
Total current assets108.19B
Goodwill5.09B
Intangible assets46.32B
Property, plant and equipment0.00
Total assets241.26B
Accounts payable15.59B
Short/Current long term debt25.78B
Total current liabilities120.94B
Total liabilities157.77B
Shareholder's equity83.49B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)78.89B
Capital expenditures (TTM)14.75B
Free cash flow (TTM)64.39B
Dividends paid (TTM)66.30B

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity66.51%
Return on Assets23.01%
Return on Invested Capital52.52%
Cash Return on Invested Capital60.91%
Loading...
AD

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open194.40
Daily high196.11
Daily low193.71
Daily Volume1.95M
All-time high195.40
1y analyst estimate152.49
Beta0.31
EPS (TTM)24.48
Dividend per share1.77
Ex-div date18 Aug 2023
Next earnings date2 Nov 2023

Downside potential

Loading...
Downside potential data
NVOS&P500
Current price drop from All-time high-0.56%-5.55%
Highest price drop-51.74%-56.47%
Date of highest drop5 Aug 20029 Mar 2009
Avg drop from high-11.14%-11.49%
Avg time to new high15 days13 days
Max time to new high1120 days1805 days
Get the latest news and real-time alerts from Novo Nordisk A/S (NVO) stock at Seeking Alpha.
September 10, 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Novo Nordisk A/S (NVO) stock at Seeking Alpha.
September 7, 2023

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
NVO (Novo Nordisk A/S) company logo
Marketcap
439.62B
Marketcap category
Large-cap
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Employees
54393
Investor relations
SEC filings
CEO
Lars Fruergaard Joergensen
Country
USA
City
Novo Alle
Stock type
American depositary share
CCC status
-
Dividend Frequency
Semi-annual
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
Get the latest news and real-time alerts from Novo Nordisk A/S (NVO) stock at Seeking Alpha.
September 5, 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Novo Nordisk A/S (NVO) stock at Seeking Alpha.
September 1, 2023

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
Get the latest news and real-time alerts from Novo Nordisk A/S (NVO) stock at Seeking Alpha.
August 31, 2023
Get the latest news and real-time alerts from Novo Nordisk A/S (NVO) stock at Seeking Alpha.
August 31, 2023
Novo Nordisk is one of the most qualitative big pharma companies globally. Read why I am bullish on NVO stock with the long-term investment horizon here.
August 31, 2023
Novo Nordisk excels in weight loss and diabetes care, showcasing strong financials & a broad product range. Click here to read an analysis on NVO stock now.
August 30, 2023
Get the latest news and real-time alerts from Novo Nordisk A/S (NVO) stock at Seeking Alpha.
August 30, 2023
Get the latest news and real-time alerts from Novo Nordisk A/S (NVO) stock at Seeking Alpha.
August 25, 2023
Eli Lilly (LLY) and Novo Nordisk's (NVO) current valuations are not sustainable and there exist numerous adverse factors. Learn what are those adverse factors.
August 24, 2023
Get the latest news and real-time alerts from Novo Nordisk A/S (NVO) stock at Seeking Alpha.
August 23, 2023
Get the latest news and real-time alerts from Novo Nordisk A/S (NVO) stock at Seeking Alpha.
August 14, 2023
The following slide deck was published by Novo Nordisk A/S in conjunction with their 2023 Q2 earnings call.
August 10, 2023
iO Charts is a Seeking Alpha partnerNext page